Risk Facotors in Young CHD Patients
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03040869|
Recruitment Status : Unknown
Verified February 2017 by Xu Lei, Shanghai Zhongshan Hospital.
Recruitment status was: Not yet recruiting
First Posted : February 2, 2017
Last Update Posted : February 2, 2017
Shanghai Zhongshan Hospital
Information provided by (Responsible Party):
Xu Lei, Shanghai Zhongshan Hospital
Coronary heart disease (CHD) is the leading global cause of human death. Over the past decade, level of overall diagnosis and treatment of CHD has been greatly improved due to the progression of clinical research and development of technical means and the mortality of CHD has decreased by nearly 50% in western countries . However, there are surveys shows that with the improvement of living standards and changes in lifestyle, the incidence of CHD is still rising in China and other developing countries, and the prevalence trend is obvious younger . The so-called young CHD, generally refers to the age at onset of CHD is less than or equal to 45 years. Compared with other age-group CHD, young CHD has the following characteristics: 1. Genetic factors have a stronger effect at younger onset ages, and incidence with obvious familial aggregation; 2 Often with the onset of acute coronary syndrome, presumably may be associated with strong inflammation of the lesion; 3. Two extremes often exists in coronary lesions: mild or no atherosclerosis and severe triple-vessel disease; 4 Rapid progression of atherosclerotic lesions, stent restenosis in the same site repeated after interventional treatment, rapid progress of lesion in non-intervention site;5 Surgical mortality is low in regardless of interventional therapy or bypass surgery, but the rate of revascularization is significantly higher in following 10 years.
|Condition or disease|
|Risk Factor, Cardiovascular, Young CHD Patients|
Show detailed description
|Study Type :||Observational [Patient Registry]|
|Estimated Enrollment :||1000 participants|
|Target Follow-Up Duration:||3 Months|
|Official Title:||Risk Factors Investigation in Young Patients With Coronary Artery Disease and Their Clinical Follow-up|
|Estimated Study Start Date :||February 1, 2017|
|Estimated Primary Completion Date :||January 31, 2020|
|Estimated Study Completion Date :||July 31, 2020|
coronary angioplasty confirmed coronary heart disease.
coronary angioplasty confirmed no coronary heart disease.
Primary Outcome Measures :
- heart failure [ Time Frame: 12 months ]LVEF less than 40%
No Contacts or Locations Provided